Question 1

Has Vikram Sahni received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,552,141 in general payments to Vikram Sahni across 592 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Vikram Sahni did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Vikram Sahni come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Astrazeneca UK Limited	28	$537,944
Merck	139	$287,700
Acerta Pharma LLC	9	$190,508
AbbVie	225	$162,225
Pharmacyclics LLC, An Abbvie Company	55	$129,110
E.r. Squibb & Sons, L.L.C.	7	$62,935
GSK	23	$52,065
Tesaro, Inc.	11	$35,050
Hoffmann-la Roche Limited	10	$34,345
Janssen Research & Development, LLC	18	$14,705
Novartis Pharma AG	12	$10,290
Verastem, Inc.	10	$8,650
Seagen Inc.	7	$7,680
Beigene, Ltd.	11	$4,910
EMD Serono, Inc.	1	$4,000
Geron Corporation	10	$2,850
Pfizer	1	$2,355
Beone Medicines Ltd.	4	$2,095
Taiho Oncology, Inc.	5	$1,100
Beigene AUS Pty Ltd	1	$735
Secura Bio, Inc.	2	$360
Takeda Pharmaceuticals U.S.A., Inc.	1	$220
Bristol Myers Squibb	1	$160
Beigene (suzhou) Co., Ltd.	1	$150

Vikram Sahni

Payments from drug & device makers

Who reported the general payments

How this compares

Other diagnostic radiology in Wellesley